EUVIMEDEUVIMED entdecken
Crossref

H 2 S-Activable BiFeO 3– x Nanocatalysts for Ferroptosis-Driven Cancer Immunotherapy

Jinzhe Liang iD, Xianliu Luo, Ya-Qian Shi, Liang-Mei Yang, Caiying Li, Lixian Huang, Yuzhen Ma, Yong Huang, Shulin Zhao iD

ACS Nano · 17.02.2026 · 20 (6) · 4953-4969

DOI: 10.1021/acsnano.5c18008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 02.02.2026. Verfasst von Jinzhe Liang und 8 weiteren Autor:innen. Beteiligte Einrichtung: MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Basic Re…. Hauptthemen laut MEDLINE: Ferroptosis, Immunotherapy, Bismuth, Hydrogen Sulfide. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, BAGUI Scholar Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisImmunotherapyBismuthHydrogen SulfideFerric CompoundsAntineoplastic AgentsNanoparticlesAnimalsCatalysisHumansMice

Stichwörter der Autor:innen

activable nanoprobecolorectal cancerferroptosisimmunotherapymass cytometry

Substanzen

BismuthHydrogen SulfideFerric CompoundsAntineoplastic Agents

Autor:innen und Institutionen

  • MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Anti-Infective Drug Discovery and Development, Guangdong Basic Research Center of Excellence for Functional Molecular Engineering, Scho…
  • Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Guangxi Key Laboratory of Chemistry and Molecular Engineering of Medicinal Resources, University Engineerin…

ORCID-Profile: Jinzhe Liang, Shulin Zhao

Förderung

  • China Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • BAGUI Scholar Program

Zitieren

APA

Liang, J., Luo, X., Shi, Y. Q., Yang, L. M., Li, C., Huang, L., Ma, Y., Huang, Y., & Zhao, S. (2026). H 2 S-Activable BiFeO 3– x Nanocatalysts for Ferroptosis-Driven Cancer Immunotherapy. ACS Nano, 20(6), 4953-4969. https://doi.org/10.1021/acsnano.5c18008

Vancouver

Liang J, Luo X, Shi YQ, Yang LM, Li C, Huang L, et al. H 2 S-Activable BiFeO 3– x Nanocatalysts for Ferroptosis-Driven Cancer Immunotherapy. ACS Nano. 2026;20(6):4953-4969. doi:10.1021/acsnano.5c18008

BibTeX
@article{Liang2026,
  author = {Liang, Jinzhe and Luo, Xianliu and Shi, Ya-Qian and Yang, Liang-Mei and Li, Caiying and Huang, Lixian and Ma, Yuzhen and Huang, Yong and Zhao, Shulin},
  title = {H 2 S-Activable BiFeO 3– x Nanocatalysts for Ferroptosis-Driven Cancer Immunotherapy},
  journal = {ACS Nano},
  year = {2026},
  volume = {20},
  number = {6},
  pages = {4953--4969},
  doi = {10.1021/acsnano.5c18008}
}
Kostenlos starten →